Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer

A Mortezavi, S Salemi, B Kranzbühler, O Gross… - World journal of …, 2019 - Springer
Purpose Abiraterone acetate (AA) plus prednisone is an approved treatment of advanced
prostate cancer (PCa). Autophagy is linked to drug resistance in numerous types of cancers …
被引用次数：24 相关文章

Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer.

A Mortezavi, S Salemi, B Kranzbühler… - World Journal of …, 2018 - europepmc.org
Purpose Abiraterone acetate (AA) plus prednisone is an approved treatment of advanced
prostate cancer (PCa). Autophagy is linked to drug resistance in numerous types of cancers …

Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer

A Mortezavi, S Salemi, B Kranzbühler… - World journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Purpose Abiraterone acetate (AA) plus prednisone is an approved treatment of advanced
prostate cancer (PCa). Autophagy is linked to drug resistance in numerous types of cancers …

Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer.

A Mortezavi, S Salemi, B Kranzbühler… - World Journal of …, 2019 - search.ebscohost.com
Purpose: Abiraterone acetate (AA) plus prednisone is an approved treatment of advanced
prostate cancer (PCa). Autophagy is linked to drug resistance in numerous types of cancers …

Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer

A Mortezavi, S Salemi, B Kranzbühler, O Gross… - World Journal of …, 2019 - zora.uzh.ch
PURPOSE: Abiraterone acetate (AA) plus prednisone is an approved treatment of advanced
prostate cancer (PCa). Autophagy is linked to drug resistance in numerous types of cancers …

[引用][C] Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer

A Mortezavi, S Salemi, B Kranzbühler, O Gross… - World Journal of …, 2018 - cir.nii.ac.jp
Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate
cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer

A Mortezavi, S Salemi, B Kranzbühler… - World Journal of …, 2019 - search.proquest.com
Purpose Abiraterone acetate (AA) plus prednisone is an approved treatment of advanced
prostate cancer (PCa). Autophagy is linked to drug resistance in numerous types of cancers …

Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer.

A Mortezavi, S Salemi, B Kranzbühler, O Gross… - World journal of …, 2019 - sonar.ch
METHODS Human PCa LNCaP cell lines were cultured in steroid-free medium and treated
with AA. Autophagy was inhibited by 3-methyladenine, chloroquine and ATG5 siRNA knock …

Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer.

A Mortezavi, S Salemi, B Kranzbühler… - World journal of …, 2019 - boris.unibe.ch
PURPOSE Abiraterone acetate (AA) plus prednisone is an approved treatment of advanced
prostate cancer (PCa). Autophagy is linked to drug resistance in numerous types of cancers …

Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer.

A Mortezavi, S Salemi, B Kranzbühler, O Gross… - World journal of …, 2019 - folia.unifr.ch
METHODS Human PCa LNCaP cell lines were cultured in steroid-free medium and treated
with AA. Autophagy was inhibited by 3-methyladenine, chloroquine and ATG5 siRNA knock …